Clinical trial
Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive…
NCT00391014 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00391014 |
|---|---|
| Title | Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis |
| Official title | AMBINEB: Clinical Trial to Evaluate Tolerance and Safety of Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis in Patients With Acute Myeloid Leukemia and Allogeneic Haematopoietic Progenitor Cell Transplant (Alo-HPCT) |
| Acronym | AMBINEB |
| Lead sponsor | PETHEMA Foundation, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Allogeneic Haematopoietic Progenitor Cell Transplant |
| Intervention type | Drug |
| Interventions | liposomal Amphotericine B |
| Enrollment | 150 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Oct 23, 2006 |
| Last update posted | May 12, 2009 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: